Growing community of inventors

Oslo, Norway

Eivind Hovig

Average Co-Inventor Count = 5.29

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Eivind Hovig ↔ Sudhir Agrawal (3 patents)Eivind Hovig ↔ Einar Nygard (10 patents)Eivind Hovig ↔ Eric Von Hofe (1 patent)Eivind Hovig ↔ Koki Yoshioka (5 patents)Eivind Hovig ↔ Oystein Fodstad (3 patents)Eivind Hovig ↔ Olav Engebraaten (3 patents)Eivind Hovig ↔ Gunhild Maelandsmo (3 patents)Eivind Hovig ↔ Arne Skretting (1 patent)Eivind HovigEivind Hovig (3 patents)Sudhir AgrawalSudhir Agrawal (152 patents)Einar NygardEinar Nygard (10 patents)Eric Von HofeEric Von Hofe (7 patents)Koki YoshiokaKoki Yoshioka (5 patents)Oystein FodstadOystein Fodstad (5 patents)Olav EngebraatenOlav Engebraaten (3 patents)Gunhild MaelandsmoGunhild Maelandsmo (3 patents)Arne SkrettingArne Skretting (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hybridon, Inc. (3 from 98 patents)

2. The Norwegian Radium Hospital Research Foundation (2 from 4 patents)

3. Biomolex As (1 patent)


3 patents:

1. 5877308 - CAPL-specific oligonucleotides and methods of inhibiting metastatic

2. 5872007 - CAPL-specific oligonucleotides and methods of inhibiting metastatic

3. 5789248 - CAPL-specific oligonucleotides and method of inhibiting metastatic cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/18/2025
Loading…